• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 6-K filed by NANO-X IMAGING LTD

    5/22/25 8:05:17 AM ET
    $NNOX
    Medical Electronics
    Health Care
    Get the next $NNOX alert in real time by email
    6-K 1 ea0241968-6k_nano.htm REPORT OF FOREIGN PRIVATE ISSUER

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON, D.C. 20549

     

    FORM 6-K

     

    REPORT OF FOREIGN PRIVATE ISSUER

    PURSUANT TO RULE 13a-16 OR 15d-16

    UNDER THE SECURITIES EXCHANGE ACT OF 1934

     

    For the month of May 2025

     

    Commission File Number: 001-39461

     

    NANO-X IMAGING LTD

     

    Ofer Tech Park

    94 Shlomo Shmeltzer Road

    Petach Tikva

    Israel 4970602

    (Address of principal executive office)

     

    Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

     

    Form 20-F ☒       Form 40-F ☐

     

     

     

     

     

     

    On May 22, 2025, NANO-X IMAGING LTD (the “Company”) issued a press release announcing the Company’s results of operation for the first quarter ended March 31, 2025, and providing a business update. A copy of that press release is attached hereto as Exhibit 99.1, and incorporated herein by reference.

     

    In addition to reporting the Company’s financial results in accordance with generally accepted accounting principles in the United States (“GAAP”), the press release also includes certain financial measures for the Company’s performance that are not prepared in accordance with GAAP due to the exclusion of certain expenses that are required to be included under GAAP.

     

    For information on the Company’s GAAP and non-GAAP financial results for the period, please refer to the press release.

     

    The GAAP financial statements tables contained in the press release attached as Exhibit 99.1 to this Report of Foreign Private Issuer on Form 6-K are incorporated by reference into the Company’s Registration Statements on Form F-3, File No. 333-271688, and Form S-8, File No. 333-248322.

     

    1

     

     

    EXHIBIT INDEX

     

    Exhibit No.   Exhibit
    99.1   Press release, dated May 22, 2025.

     

    2

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

     

      NANO-X IMAGING LTD
       
      By: /s/ Ran Daniel
      Name:  Ran Daniel
      Title: Chief Financial Officer

     

    Date: May 22, 2025

     

     

    3

     

    Get the next $NNOX alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $NNOX

    DatePrice TargetRatingAnalyst
    1/6/2025$23.00Buy
    D. Boral Capital
    9/8/2023$14.50Buy
    Alliance Global Partners
    1/5/2023$21.00Overweight
    Cantor Fitzgerald
    More analyst ratings

    $NNOX
    Leadership Updates

    Live Leadership Updates

    See more
    • Nanox Announces Appointment of Medical Executive Moshe Shtengel as Chief Business Officer

      NEVE ILAN, Israel, May 03, 2021 (GLOBE NEWSWIRE) -- NANOX IMAGING LTD (NASDAQ:NNOX) ("Nanox" or the "Company"), an innovative medical imaging technology company, announced today the appointment of Moshe Shtengel as Chief Business Officer, effective May 2, 2021. Mr. Shtengel joins Nanox from Tuttnauer, a global manufacturer of sterilizers and infection control systems for medical institutions, where he served as Vice President of Global Sales, Marketing and Products. "Moshe is an extremely seasoned sales and business development executive with a proven track record of success and leadership in the medical field," stated Ran Poliakine, Chairman and Chief Executive Officer of Nanox. "As we

      5/3/21 8:00:00 AM ET
      $NNOX
      Medical Electronics
      Health Care

    $NNOX
    Financials

    Live finance-specific insights

    See more
    • Nanox Announces First Quarter 2025 Financial Results and Provides Business Updates

      PETACH TIKVA, Israel, May 22, 2025 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (NASDAQ:NNOX) ("Nanox" or the "Company"), an innovative medical imaging technology company, today announced results for the first quarter ended March 31, 2025, and provided a business update. Recent Highlights: Generated $2.8 million in revenue in the first quarter of 2025, compared to $2.6 million in the first quarter of 2024.Received 510(k) clearance from the FDA for the Nanox.ARC X, its updated multi-source digital Tomosynthesis system.Signed multiple commercial agreements to market the Nanox.ARC and the Nanox.AI solutions. "Since the beginning of 2025, Nanox has made consistent progress marketing our full end-

      5/22/25 8:00:00 AM ET
      $NNOX
      Medical Electronics
      Health Care
    • Nanox to Report First Quarter 2025 Financial Results on May 22, 2025

      PETACH TIKVA, Israel, May 08, 2025 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ((", Nanox", or the ", Company", , NASDAQ:NNOX), an innovative medical imaging technology company, today announced that it will report its financial results for the quarter ended March 31, 2025, before market open on Thursday, May 22, 2025. Erez Meltzer, Chief Executive Officer and Acting Chairman, and Ran Daniel, Chief Financial Officer, will host a conference call to review these results and provide a business update beginning at 8:30 a.m. ET. Interested parties may register for the conference call using the following link: Nanox Q1 2025 Earnings Call Registration. The live webcast of the conference call may be

      5/8/25 4:03:00 PM ET
      $NNOX
      Medical Electronics
      Health Care
    • Nanox to Report Fourth Quarter and Fiscal Year 2024 Financial Results on March 31, 2025

      PETACH TIKVA, Israel, March 17, 2025 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ((", Nanox", or the ", Company", , NASDAQ:NNOX), an innovative medical imaging technology company, today announced that it will report its financial results for the quarter and fiscal year ended December 31, 2024, before market open on Monday, March 31, 2025. Erez Meltzer, Chief Executive Officer and Acting Chairman, and Ran Daniel, Chief Financial Officer, will host a conference call to review these results and provide a business update beginning at 8:30 a.m. ET. Interested parties may register for the conference call using the following link: Nanox Q4 Earnings Call Registration. The live webcast of the conferenc

      3/17/25 4:05:00 PM ET
      $NNOX
      Medical Electronics
      Health Care

    $NNOX
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Nanox Announces First Quarter 2025 Financial Results and Provides Business Updates

      PETACH TIKVA, Israel, May 22, 2025 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (NASDAQ:NNOX) ("Nanox" or the "Company"), an innovative medical imaging technology company, today announced results for the first quarter ended March 31, 2025, and provided a business update. Recent Highlights: Generated $2.8 million in revenue in the first quarter of 2025, compared to $2.6 million in the first quarter of 2024.Received 510(k) clearance from the FDA for the Nanox.ARC X, its updated multi-source digital Tomosynthesis system.Signed multiple commercial agreements to market the Nanox.ARC and the Nanox.AI solutions. "Since the beginning of 2025, Nanox has made consistent progress marketing our full end-

      5/22/25 8:00:00 AM ET
      $NNOX
      Medical Electronics
      Health Care
    • Nanox to Report First Quarter 2025 Financial Results on May 22, 2025

      PETACH TIKVA, Israel, May 08, 2025 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ((", Nanox", or the ", Company", , NASDAQ:NNOX), an innovative medical imaging technology company, today announced that it will report its financial results for the quarter ended March 31, 2025, before market open on Thursday, May 22, 2025. Erez Meltzer, Chief Executive Officer and Acting Chairman, and Ran Daniel, Chief Financial Officer, will host a conference call to review these results and provide a business update beginning at 8:30 a.m. ET. Interested parties may register for the conference call using the following link: Nanox Q1 2025 Earnings Call Registration. The live webcast of the conference call may be

      5/8/25 4:03:00 PM ET
      $NNOX
      Medical Electronics
      Health Care
    • Nanox Receives FDA Clearance for General Use of New Imaging System, Nanox.ARC X

      First FDA clearance for Nanox.ARC X to produce tomographic images for general use, including musculoskeletal, pulmonary, intra-abdominal and paranasal indicationsEnhanced imaging system features sleek design with smaller footprint; simplified ‘plug and play' installation processSystem design enables software upgrades and new capabilities to be added remotely following future regulatory clearances PETACH TIKVA, Israel, April 17, 2025 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ((", Nanox", or the ", Company", , NASDAQ:NNOX), an innovative medical imaging technology company, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the Nanox.ARC X

      4/17/25 8:30:54 AM ET
      $NNOX
      Medical Electronics
      Health Care

    $NNOX
    SEC Filings

    See more
    • SEC Form 6-K filed by NANO-X IMAGING LTD

      6-K - Nano-X Imaging Ltd. (0001795251) (Filer)

      5/22/25 8:05:17 AM ET
      $NNOX
      Medical Electronics
      Health Care
    • SEC Form 6-K filed by NANO-X IMAGING LTD

      6-K - Nano-X Imaging Ltd. (0001795251) (Filer)

      4/17/25 8:40:02 AM ET
      $NNOX
      Medical Electronics
      Health Care
    • SEC Form 20-F filed by NANO-X IMAGING LTD

      20-F - Nano-X Imaging Ltd. (0001795251) (Filer)

      4/9/25 4:29:36 PM ET
      $NNOX
      Medical Electronics
      Health Care

    $NNOX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • D. Boral Capital initiated coverage on Nano-X Imaging with a new price target

      D. Boral Capital initiated coverage of Nano-X Imaging with a rating of Buy and set a new price target of $23.00

      1/6/25 9:02:00 AM ET
      $NNOX
      Medical Electronics
      Health Care
    • Alliance Global Partners initiated coverage on Nano-X Imaging with a new price target

      Alliance Global Partners initiated coverage of Nano-X Imaging with a rating of Buy and set a new price target of $14.50

      9/8/23 9:14:06 AM ET
      $NNOX
      Medical Electronics
      Health Care
    • Cantor Fitzgerald initiated coverage on Nano-X Imaging with a new price target

      Cantor Fitzgerald initiated coverage of Nano-X Imaging with a rating of Overweight and set a new price target of $21.00

      1/5/23 7:46:34 AM ET
      $NNOX
      Medical Electronics
      Health Care

    $NNOX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by NANO-X IMAGING LTD (Amendment)

      SC 13G/A - Nano-X Imaging Ltd. (0001795251) (Subject)

      3/7/24 12:29:51 PM ET
      $NNOX
      Medical Electronics
      Health Care
    • SEC Form SC 13G filed by NANO-X IMAGING LTD

      SC 13G - Nano-X Imaging Ltd. (0001795251) (Subject)

      2/6/24 9:36:34 AM ET
      $NNOX
      Medical Electronics
      Health Care
    • SEC Form SC 13G/A filed by NANO-X IMAGING LTD (Amendment)

      SC 13G/A - Nano-X Imaging Ltd. (0001795251) (Subject)

      2/14/23 4:15:16 PM ET
      $NNOX
      Medical Electronics
      Health Care